Verition Fund Management’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.5M | Buy |
150,648
+106,500
| +241% | +$1.06M | 0.01% | 1614 |
|
2025
Q1 | $264K | Sell |
44,148
-54,551
| -55% | -$326K | ﹤0.01% | 2278 |
|
2024
Q4 | $758K | Buy |
98,699
+71,901
| +268% | +$552K | ﹤0.01% | 1660 |
|
2024
Q3 | $274K | Sell |
26,798
-4,916
| -16% | -$50.2K | ﹤0.01% | 2022 |
|
2024
Q2 | $471K | Buy |
+31,714
| New | +$471K | ﹤0.01% | 1489 |
|
2023
Q4 | – | Sell |
-94,824
| Closed | -$1.04M | – | 2052 |
|
2023
Q3 | $1.04M | Sell |
94,824
-21,459
| -18% | -$235K | 0.01% | 904 |
|
2023
Q2 | $1.54M | Buy |
+116,283
| New | +$1.54M | 0.02% | 687 |
|
2022
Q1 | – | Sell |
-6,435
| Closed | -$300K | – | 2080 |
|
2021
Q4 | $300K | Buy |
+6,435
| New | +$300K | ﹤0.01% | 1380 |
|